These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17197486)

  • 1. Improvement of endothelial function with allopurinol may occur in selected patients with OSA: effect of age and sex.
    Teramoto S; Kume H; Yamaguchi Y; Yamamoto H; Hanaoka Y; Ishii M; Ishii T; Ouchi Y
    Eur Respir J; 2007 Jan; 29(1):216-7; author reply 217-8. PubMed ID: 17197486
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study.
    El Solh AA; Saliba R; Bosinski T; Grant BJ; Berbary E; Miller N
    Eur Respir J; 2006 May; 27(5):997-1002. PubMed ID: 16707395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Xin W; Mi S; Lin Z
    Cardiovasc Ther; 2016 Dec; 34(6):441-449. PubMed ID: 27542348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol use is associated with greater functional gains in older rehabilitation patients.
    Beveridge LA; Ramage L; McMurdo ME; George J; Witham MD
    Age Ageing; 2013 May; 42(3):400-4. PubMed ID: 23542724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol and endothelial function in heart failure: future or fantasy?
    Landmesser U; Drexler H
    Circulation; 2002 Jul; 106(2):173-5. PubMed ID: 12105153
    [No Abstract]   [Full Text] [Related]  

  • 6. Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
    Doehner W; Anker SD
    Heart; 2005 Jun; 91(6):707-9. PubMed ID: 15894755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase inhibition prevents mesenteric blood flow deficits after resuscitated hemorrhagic shock by preserving endothelial function.
    Flynn WJ; Pilati D; Hoover EL
    J Surg Res; 1997 Mar; 68(2):175-80. PubMed ID: 9184677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a xanthine oxidase inhibitor in autoimmune hepatitis.
    Al-Shamma S; Eross B; Mclaughlin S
    Hepatology; 2013 Mar; 57(3):1281-2. PubMed ID: 23238820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease.
    Landmesser U; Spiekermann S; Preuss C; Sorrentino S; Fischer D; Manes C; Mueller M; Drexler H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):943-8. PubMed ID: 17234726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of disseminated granuloma annulare with allopurinol: case report.
    Mazzatenta C; Ghilardi A; Grazzini M
    Dermatol Ther; 2010; 23 Suppl 1():S24-7. PubMed ID: 20136918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol treatment reduces arterial wave reflection in stroke survivors.
    Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
    Cardiovasc Ther; 2008; 26(4):247-52. PubMed ID: 19035875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Xanthine Oxidase Inhibitors Improve Cardiac Function in Patients With Chronic Heart Failure?
    Sugihara S; Yamamoto K; Hisatome I
    Int Heart J; 2016 Dec; 57(6):661-662. PubMed ID: 27818485
    [No Abstract]   [Full Text] [Related]  

  • 13. Kyrle's disease successfully treated with allopurinol.
    Shih CJ; Tsai TF; Huang H; Ko WC; Hung CM
    Int J Dermatol; 2011 Sep; 50(9):1170-2. PubMed ID: 22126887
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.
    Gardiner SJ; Gearry RB; Burt MJ; Chalmers-Watson T; Chapman BA; Ross AG; Stedman CA; Huelsen A; Barclay ML
    J Gastroenterol Hepatol; 2011 Jan; 26(1):49-54. PubMed ID: 21175793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.
    Mercuro G; Vitale C; Cerquetani E; Zoncu S; Deidda M; Fini M; Rosano GM
    Am J Cardiol; 2004 Oct; 94(7):932-5. PubMed ID: 15464681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
    Kittleson MM; Hare JM
    Eur Heart J; 2005 Aug; 26(15):1458-60. PubMed ID: 15917281
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.
    Dawson J; Quinn TJ; Harrow C; Lees KR; Walters MR
    Br J Clin Pharmacol; 2009 Nov; 68(5):662-8. PubMed ID: 19916990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol induced meningitis.
    Duchene DA; Smith CP; Goldfarb RA
    J Urol; 2000 Dec; 164(6):2028. PubMed ID: 11061913
    [No Abstract]   [Full Text] [Related]  

  • 20. Febuxostat versus allopurinol for gout.
    Lustberg ME
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16598054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.